Biova LLC announces new, second location in Kansas Bioscience Park

Human Health published Wed, 2014-09-24 10:57

Johnston, Iowa, USA—Biova LLC, the world leader for water soluble egg membrane ingredients, has expanded their cutting-edge technology into a new neighborhood.

The new Biova office at 10900 S.Clay Blair Blvd in Olathe, Kans., is located in the Venture Accelerator at the Kansas Bioscience Park, next to some of the leading—and fastest growing—science and technology businesses in the United States.

“Our expansion is so much more than elbow room,” said Matt Stegenga, Biova’s director of marketing. “There are great things happening at Biova. We wanted a scientific, collaborative community that understands the needs of growing technology companies. Kansas Bioscience Park checked all our boxes.”

The new Biova Olathe office will focus on managing the burgeoning product development and marketing operations for Biova’s egg membrane technologies and branded ingredients. Kathy Hockla, project manager, has been hired joining Stegenga in Biova's new Olathe offices.

About Biova:
Privately held and globally distributed, Biova is the market leader for water soluble egg membrane ingredients offering proven health benefits: BiovaFlex for joint health; BiovaDerm for skin care; and BiovaPlex® for animal health. Biova's patented water soluble process creates expanded delivery options for consumer products, including functional foods, beverages,lotions and more. Years of dedicated investment, ongoing scientific research and leading-edge technology are at the core of
these all-natural, ultra-pure, nutrient-rich ingredients. A focus on sustainable production, anchored by vertical integration with the largest U.S. egg producing and processing partners, assures Biova an almost unlimited supply of 100% U.S. domestic sourced raw material.


Aratana seeks more than $40M in latest public stock offering

Animal Health published Thu, 2014-09-18 09:59

Aratana Therapeutics Inc. announced Wednesday it will offer 4.5 million shares of its common stock at $9.25 a share, which would raise about $41.6 million.

The Kansas City, Kan., animal health company announced its third public stock offering Wednesday.

According to information filed with the Securities and Exchange Commission, Aratana (Nasdaq: PETX) plans to use a portion of the proceeds to expand its commercial infrastructure in anticipation of future product launches. It also may use the money to in-license or acquire additional technologies or businesses, and continue development of its current technologies.

Aratana has spent the last year actively acquiring new companies and technologies to build its pipeline of therapies for companion animals.

In October 2013 the company entered the canine cancer business with its acquisition of San Diego-based Vet Therapeutics Inc.

Shortly after, it announced it had purchased Belgium-based Okapi Sciences, which is developing a handful of clinical-stage therapeutics for treating viral diseases in companion animals.

Later in 2014, Aratana licensed the right to commercialize human cancer products owned by Advaxis Inc. for use in pets. It also licensed a stem cell therapy from Vet-Stem Inc. that it plans to develop to treat osteoarthritis in dogs.

Reported by:

- Brianne Pfannenstiel, Kansas City Business Journal


Sprint Accelerator powered by Techstars - Healthcare Reverse Pitch

Human Health published Tue, 2014-09-16 09:30

Techstars, Sprint, and KU Med are joining forces to host an evening of reverse pitch - instead of a startup pitching their business, healthcare experts will be pitching challenges to an audience of innovators capable of building a solution. Mobile health companies, this is your opportunity to meet with Techstars and Sprint and find out what it takes to get accepted into the next class of the Sprint Accelerator powered by Techstars.  Join us Wednesday, October 8th at the Sprint Accelerator, 210 W 19th Terrace, Kansas City, MO  64108, from 5:00 - 7:00 p.m.
5:00     Appetizers, drinks & networking
5:30     Presentation on Techstars and the Sprint Mobile Health Accelerator
6:00     Reverse pitches begin
Entrepreneurs, developers, business leaders, interested community members - listen to the pitches and collaborate on solutions. Healthcare professionals, students, researchers and administrators - SUBMIT YOUR PITCH HERE. All are invited to attend to help collaborate and innovate solutions - you just might walk away having created one of the newest mobile health companies! Join the conversation at #mhealthkc!
For more information or to register, go to Reverse Pitch.
Techstars is a mentoriship-driven startup accelerator with a massive interconnected network of over 3,000 successful entrepreneurs, mentors, investors and corporate partners. With 13 programs worldwide, Techstars funds the best companies in the most entrepreneurial communities. 
Collab is a University of Kansas and KU Medical Center student-led organization connecting innovators on campus and in the community. 
Kansas Bioscience Authorty is a co-sponsor of this event. With a focus on human health, animal health and agribusiness, KBA brings deep industry expertise and capital raising experience to bioscience startups, serving the entrepreneur, co-investors and Kansas.